Premier Perspectives The blog for insider insights in clinical development COVID-19 COVID-19 & Clinical Trials: Direct-to-Patient Model Keeps Research Moving and Patients Safe By Andrea Ochoa April 7, 2020 × ALSO OF INTERESTPREMIER VOICES #12: Direct-to-Patient – Is...Management TeamWelcome to Premier Perspectives!
